pharmaceutical | DD News

September 25, 2026 4:56 PM

PLI schemes strengthen India’s pharmaceutical, bulk drugs and medical devices manufacturing ecosystem

The Production Linked Incentive (PLI) schemes implemented by the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers have helped expand domestic manufacturing in India's pharmaceutical and medical devices sectors, reduce import dependence and promote technology adoption, according to the government. The initiatives cover critical pharmaceutical raw materials, high-value medicines and advanced medical devices and are aimed at strengthening manufacturing capabilities...

February 22, 2026 11:43 AM

India, Brazil sign MoU to boost cooperation in pharmaceutical and medical product regulation

India and Brazil on Saturday exchanged a Memorandum of Understanding (MoU) aimed at strengthening bilateral cooperation in the regulation of pharmaceutical and medical products, marking a significant step in expanding health sector collaboration between the two countries. The MoU was signed between India’s Central Drugs Standard Control Organisation (CDSCO) and Brazil’s Brazilian Health Regulatory Agency (ANVISA) at Hyderabad House. The agreement was exchanged by ANVISA Director-President L...

September 30, 2025 6:42 PM

India’s pharma exports to cross $30 billion by year-end, domestic market to double by 2030: Jitendra Singh

India’s pharmaceutical exports, currently valued at nearly $27.8 billion, are set to cross the $30 billion mark by the end of this year, Union Minister of State (Independent Charge) for Science and Technology Dr. Jitendra Singh said on Tuesday. The Minister added that the country’s domestic pharma market, now at $60 billion, is expected to double to $130 billion by 2030. He also underlined the rapid expansion of India’s MedTech sector, which is growing at an annual rate of 15-20%, support...

March 10, 2025 4:53 PM

Indian pharma market to grow 8-9 per cent in FY26: report

The Indian pharmaceutical market is expected to grow 8-9 per cent year-on-year in FY26, according to a report on Monday. The report by India Ratings and Research (Ind-Ra) said the growth in the sector will be at 7.5-8.0 per cent year-on-year for FY25. This is “against 6.5 per cent year-on-year in FY24 and 9.9 per cent YoY growth in FY23,” said Krishnanath Munde, associate director at India Ratings and Research. In February, the pharma market delivered revenue growth of 7.5 per cent year-o...